{"entity":{"id":"susan-g-komen","kind":"collection","name":"Susan G. Komen","aka":[],"tldr":"Susan G. Komen is the best-known breast cancer charity, founded in 1982. It has granted more than $1 billion for research, including early support for HER2-directed therapy, runs a helpline and treatment assistance programme, and holds ShareForCures, a patient-consented registry that shares data for metastatic breast cancer research.","summary":"Founded 1982. Beyond awareness (the pink ribbon), Komen funds research including early support for HER2-directed therapy and metastatic breast cancer studies, runs the Breast Care Helpline and Treatment Assistance Program, the Komen Tissue Bank at IU Simon (normal breast tissue), ShareForCures (patient-consented data and biospecimens), and advocates on stage IV disease, disparities (Stand for H.E.R. for Black women) and coverage of diagnostic imaging. Other key groups: Breast Cancer Research Foundation (research funding), Living Beyond Breast Cancer, METAvivor (metastatic research), Young Survival Coalition.","asOf":"2026-09-08","links":[{"label":"Susan G. Komen","url":"https://www.komen.org/"},{"label":"Breast Cancer Research Foundation","url":"https://www.bcrf.org/"},{"label":"METAvivor","url":"https://www.metavivor.org/"}],"tags":["gap-fill","patient-org"],"related":["breast-hr-positive","breast-her2-positive","tnbc","mammography","brca","src-lbbc"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":["cancer-health-disparities"],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"url":"https://www.komen.org/","holds":"Breast cancer patient helpline and financial assistance, ShareForCures patient-powered research registry, research grants (>$1 billion to date), the Komen Tissue Bank, and policy advocacy on screening and treatment access.","license":"Copyright Komen","maintainer":"Susan G. Komen"},"route":"/collections/susan-g-komen/","neighbours":{"cancer":[{"id":"breast-her2-positive","kind":"cancer","name":"HER2-positive breast cancer","route":"/cancers/breast-her2-positive/"},{"id":"breast-hr-positive","kind":"cancer","name":"HR-positive / HER2-negative breast cancer","route":"/cancers/breast-hr-positive/"},{"id":"tnbc","kind":"cancer","name":"Triple-negative breast cancer (TNBC)","route":"/cancers/tnbc/"}],"technology":[{"id":"mammography","kind":"technology","name":"Mammography & tomosynthesis","route":"/technologies/mammography/"}],"target":[{"id":"brca","kind":"target","name":"BRCA1 / BRCA2 (HRD)","route":"/targets/brca/"}],"collection":[{"id":"src-lbbc","kind":"collection","name":"Living Beyond Breast Cancer","route":"/collections/src-lbbc/"}],"term":[{"id":"cancer-health-disparities","kind":"term","name":"Cancer health disparities and equity","route":"/terms/cancer-health-disparities/"}],"person":[{"id":"nancy-brinker","kind":"person","name":"Nancy Brinker","route":"/people/nancy-brinker/"}]}}